SmallCapNewsRelease: Oculus (NASDAQ: OCLS) Reduces Expenses $2.5 Million for Q4
JERICHO, NY, September 20, 2012, Oculus Innovative Sciences, Inc. (NASDAQ: OCLS) a commercial healthcare compan that designs, produces and markets safe and effective healthcare products announced today that they have reduced expenses for the end of Q3 2012 and into Q4 2012.
Occulus has also transitioned marketing and sales to More Pharma in Mexico, which should help the commercialization of Microcyn Technology into six Latin America and Caribbean nations. More Pharma is a pharmaceutical company with strong growth performance and a team of more than 300 people. The company has a talented sales and marketing team with significant prior experience with large international pharmaceutical companies. They have ample funding and support by their renowned financial sponsors, Southern Cross Group and Evercore, both of which manage more than $1 billion of venture funds.
Oculus is pioneering innovative solutions in multiple markets including dermatology, surgical, wound care, animal healthcare and others, and has commercialized products in the United States, Europe, India, China and Mexico and select Middle East countries. The company’s headquarters are in Petaluma, California, with manufacturing operations in the United States and Latin America.
To view the entire press release, please visit http://finance.yahoo.com/news/oculus-innovative-sciences-updates-guidance-120800058.html
SmallCapNewsRelease Healthcare Gainers Are: Synergetics USA (NASDAQ: SURG), ACADIA Pharma (NASDAQ: ACAD), BioDelivery Sciences (NASDAQ: BDSI), Nektar Therapeutics (NASDAQ: NKTR) and Savient Pharma (NASDAQ: SVNT)
SmallCapNewsRelease Healthcare Decliners Are: Arena Pharma (NASDAQ: ARNA), Dendreon Corp (NASDAQ: DNDN), Orexigen Therapeutics (NASDAQ: OREX), Avanir Pharma (NASDAQ: AVNR), and Threshold Pharma (NASDAQ: THLD)
This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Information, opinions and analysis contained herein are based on sources deemed to be reliable and are subject to change without notice. A third party has hired and paid SmallCapNewsRelease one thousand two hundred and ninety five dollars for the publication and circulation of this news release. Accordingly, certain information included herein may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. However, no representation, expressed or implied, is made as to the accuracy, completeness or correctness. In light of the above, we accept no liability for any losses arising from an investor’s reliance on or use of this report. We do not and have not had any ownership interest in said third party of any kind.
- Contact Information
- Eric Jensen
- Media Contact
- (1) 5169424910
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.